| Financial Year |
March 31 2023 |
| Monetary Funds |
377,763,464.11 |
| Held-for-trading Financial Assets |
255,300,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
943,500,407.15 |
| Advances to Suppliers |
155,211,613.08 |
| Other Receivables |
50,742,651.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,653,164,154.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,960,279.48 |
| Total Current Assets |
4,457,642,569.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,113,284,942.76 |
| Under-construction Projects |
62,697,994.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,988,127.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
21,810,941.02 |
| Deferred Income Tax Assets |
57,712,643.78 |
| Other Non-Current Assets |
6,081,363.12 |
| Sub-Total of Non-Current Assets |
1,391,534,268.65 |
| Total Assets |
5,849,176,838.20 |
| Short-Term Loans |
1,290,947,696.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
529,778,210.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,459,792.12 |
| Taxes Payable |
7,064,208.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
104,430,873.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
146,316,655.84 |
| Other Current Liabilities |
16,703,091.27 |
| Sub-Total of Current Liabilities |
2,209,634,083.34 |
| Long-term Loans |
210,958,668.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
124,201,170.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
444,242,047.91 |
| Total Liabilities |
2,653,876,131.25 |
| Paid-In Capital(Or Share Stock) |
1,130,528,253.00 |
| Capital Surplus |
1,952,658,120.75 |
| Surplus Reserve |
102,375,416.42 |
| LESS:Treasury Stock |
5,123,390.61 |
| Undistributed Profits |
-77,047,222.94 |
| Minority Stockholder's Interest |
74,010,476.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,121,290,230.81 |
| Owner's Equity（Stockholder's Equity） |
3,195,300,706.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,849,176,838.20 |
